Cargando…
Psammaplysins: Insights from Natural Sources, Structural Variations, and Pharmacological Properties
Marine natural products (MNPs) continue to be in the spotlight in the global drug discovery endeavor. Currently, more than 32,000 structurally diverse secondary metabolites from marine sources have been isolated, making MNPs a vital source for researchers to look for novel drug candidates. The marin...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693029/ https://www.ncbi.nlm.nih.gov/pubmed/36354986 http://dx.doi.org/10.3390/md20110663 |
_version_ | 1784837432002215936 |
---|---|
author | Youssef, Diaa T. A. Shaala, Lamiaa A. |
author_facet | Youssef, Diaa T. A. Shaala, Lamiaa A. |
author_sort | Youssef, Diaa T. A. |
collection | PubMed |
description | Marine natural products (MNPs) continue to be in the spotlight in the global drug discovery endeavor. Currently, more than 32,000 structurally diverse secondary metabolites from marine sources have been isolated, making MNPs a vital source for researchers to look for novel drug candidates. The marine-derived psammaplysins possess the rare and unique 1,6-dioxa-2-azaspiro [4.6] undecane backbone and are represented by 44 compounds in the literature, mostly from sponges of the order Verongiida. Compounds with 1,6-dioxa-2-azaspiro [4.6] undecane moiety exist in the literature under five names, including psammaplysins, ceratinamides, frondoplysins, ceratinadins, and psammaceratins. These compounds displayed significant biological properties including growth inhibitory, antimalarial, antifouling, protein tyrosine phosphatase inhibition, antiviral, immunosuppressive, and antioxidant effects. In this review, a comprehensive literature survey covering natural occurrence of the psammaplysins and related compounds, methods of isolation, structural differences, the biogenesis, and biological/pharmacological properties, will be presented. |
format | Online Article Text |
id | pubmed-9693029 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96930292022-11-26 Psammaplysins: Insights from Natural Sources, Structural Variations, and Pharmacological Properties Youssef, Diaa T. A. Shaala, Lamiaa A. Mar Drugs Review Marine natural products (MNPs) continue to be in the spotlight in the global drug discovery endeavor. Currently, more than 32,000 structurally diverse secondary metabolites from marine sources have been isolated, making MNPs a vital source for researchers to look for novel drug candidates. The marine-derived psammaplysins possess the rare and unique 1,6-dioxa-2-azaspiro [4.6] undecane backbone and are represented by 44 compounds in the literature, mostly from sponges of the order Verongiida. Compounds with 1,6-dioxa-2-azaspiro [4.6] undecane moiety exist in the literature under five names, including psammaplysins, ceratinamides, frondoplysins, ceratinadins, and psammaceratins. These compounds displayed significant biological properties including growth inhibitory, antimalarial, antifouling, protein tyrosine phosphatase inhibition, antiviral, immunosuppressive, and antioxidant effects. In this review, a comprehensive literature survey covering natural occurrence of the psammaplysins and related compounds, methods of isolation, structural differences, the biogenesis, and biological/pharmacological properties, will be presented. MDPI 2022-10-25 /pmc/articles/PMC9693029/ /pubmed/36354986 http://dx.doi.org/10.3390/md20110663 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Youssef, Diaa T. A. Shaala, Lamiaa A. Psammaplysins: Insights from Natural Sources, Structural Variations, and Pharmacological Properties |
title | Psammaplysins: Insights from Natural Sources, Structural Variations, and Pharmacological Properties |
title_full | Psammaplysins: Insights from Natural Sources, Structural Variations, and Pharmacological Properties |
title_fullStr | Psammaplysins: Insights from Natural Sources, Structural Variations, and Pharmacological Properties |
title_full_unstemmed | Psammaplysins: Insights from Natural Sources, Structural Variations, and Pharmacological Properties |
title_short | Psammaplysins: Insights from Natural Sources, Structural Variations, and Pharmacological Properties |
title_sort | psammaplysins: insights from natural sources, structural variations, and pharmacological properties |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693029/ https://www.ncbi.nlm.nih.gov/pubmed/36354986 http://dx.doi.org/10.3390/md20110663 |
work_keys_str_mv | AT youssefdiaata psammaplysinsinsightsfromnaturalsourcesstructuralvariationsandpharmacologicalproperties AT shaalalamiaaa psammaplysinsinsightsfromnaturalsourcesstructuralvariationsandpharmacologicalproperties |